PDCD1 and neoplasm: The main reason for the unsatisfactory effects of PD-1 antibodies can be summarized into four points: 1) insufficient immunogenicity of TSA: the lack of highly immunogenic TSA resulting in the inability of T cells to recognize tumor cells.